Health & Safety Industry Today

Heart Failure POC & LOC Devices Market to Reach USD 286.42 million by 2030 |SNS Insider

Heart Failure POC & LOC Devices Market to Witness Major Traction Driven by Rising Demand for Home Healthcare and Supportive Government Initiatives
Published 01 August 2023

The "Heart Failure POC & LOC Devices Market Report" provides a comprehensive analysis of the current and future trends in the market for point-of-care (POC) and lab-on-a-chip (LOC) devices used in the management of heart failure. This report aims to provide valuable insights into the market dynamics, competitive landscape, and growth opportunities for key players operating in this space.

Market Scope & Overview

Based on the data from SNS Insider, the heart failure POC & LOC devices market was valued at USD 83.84 million in 2022. It is projected to experience significant growth, reaching USD 286.42 million by 2030, with a Compound Annual Growth Rate (CAGR) of 16.6% during the forecast period from 2023 to 2030.

Heart failure Point-of-Care (POC) and Long-term Outpatient Care (LOC) devices are innovative medical technologies designed to improve the management and monitoring of patients with heart failure. POC and LOC devices play a crucial role in enhancing patient outcomes, reducing hospital readmissions, and increasing the overall quality of life for heart failure patients.

Key Players Covered in Heart Failure POC & LOC Devices market report are: Abaxis, Inc., bioMérieux S.A, Danaher, Abbott, Siemens Healthineers, Hoffmann-La Roche Ltd., Instrumentation Laboratory Company, Jant Pharmacal Corporation, Quidel Corporation, and Trinity Biotech and Other Players

Get Report Sample @ https://www.snsinsider.com/sample-request/2565

Market Analysis

Recent technological advancements have revolutionized the field of cardiac monitoring, with devices becoming more compact, accurate, and user-friendly. The integration of wearable technology and telehealth solutions has further extended the capabilities of these devices, enhancing patient compliance and overall disease management. Governments and private payers have increasingly recognized the value of remote patient monitoring and preventive care. As a result, there have been improvements in reimbursement policies, incentivizing healthcare providers to invest in POC and LOC devices for heart failure management. All these factors to propel growth of the heart failure POC & LOC devices market.

Impact of Recession

A recession can have a multifaceted impact on the heart failure POC & LOC devices market. From reduced disposable income and healthcare spending to disruptions in supply chains and delayed technological advancements, the market may face several challenges during an economic downturn. However, it is crucial to recognize that the healthcare industry, including medical device manufacturers, often demonstrates resilience and adaptability during challenging times. As economic conditions improve, the demand for heart failure POC and LOC devices is likely to rebound, fueled by ongoing efforts to improve patient care and outcomes.

Segmentation Analysis

As proteomic testing and Hospitals & Clinics join forces, the heart failure POC & LOC devices market is poised for unprecedented growth. The integration of advanced proteomic technologies within the clinical setting will enhance the accuracy of heart failure diagnosis, enabling early detection and personalized treatment. By leveraging their extensive expertise and patient reach, Hospitals & Clinics will play a crucial role in driving the adoption of these innovative diagnostic tools, ultimately improving patient outcomes and revolutionizing heart failure management.

Heart Failure POC & LOC Devices Market Segmentation as Follows:

By Test Type

·        Proteomic Testing

·        Metabolomic Testing

·        Genomic Testing

By Technology

·        Microfluidics

·        Array-based Systems

By End User

·        Hospitals &Clinics

·        Homecare

·        Specialty Centers

Get Free Quarterly Updates, click on the link to enquire more @ https://www.snsinsider.com/enquiry/2565

Regional Status & Analysis

The heart failure POC & LOC devices market represents a remarkable advancement in modern healthcare, providing faster, more accessible, and personalized diagnostics and monitoring for patients with heart failure. North America's role in driving the growth and dominance of this market cannot be overstated, as its robust research infrastructure, supportive regulatory environment, and substantial healthcare investments continue to pave the way for innovative medical technologies.

Conclusion

The market holds promising prospects for addressing the challenges posed by heart failure on a global scale. As technology continues to evolve, these devices will play a pivotal role in early detection, continuous monitoring, and personalized management of heart failure, thereby improving patient outcomes and reducing healthcare costs.

Frequently Asked Questions/ Key Reasons to Purchase this Report

What is the projected outlook for heart failure POC & LOC devices market growth?

·        The market for point-of-care (POC) and lab-on-a-chip (LOC) devices for heart failure is projected to exceed USD 286.42 million by the year 2030.

What are the major factors influencing the heart failure POC & LOC devices market?

·        With supportive government policies and increasing awareness about preventive healthcare, the adoption of POC and LOC devices for heart failure management is expected to grow steadily, ultimately benefiting patients and the healthcare industry as a whole.

Who are the leading players in the heart failure POC & LOC devices market?

·        Abaxis, Inc., Abbott, Siemens Healthineers, Hoffmann-La Roche Ltd., Instrumentation Laboratory Company, Quidel Corporation, and Trinity Biotech.

Table of Content

Chapter 1 Introduction 

Chapter 2 Research Methodology

Chapter 3 Market Dynamics

Chapter 4. Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Heart Failure POC & LOC Devices Market Segmentation, By Test Type

Chapter 9 Heart Failure POC & LOC Devices Market Segmentation, By Technology

Chapter 10 Heart Failure POC & LOC Devices Market Segmentation, By End User

Chapter 11 Regional Analysis

Chapter 12 Company profile

Chapter 13 Competitive Landscape

Chapter 14 Use Case and Best Practices

Chapter 15 Conclusion

Buy Heart Failure POC & LOC Devices Market Report @ https://www.snsinsider.com/checkout/2565

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com/

Other Industry News

Ready to start publishing

Sign Up today!